<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="nocebo responses in clinical trials of monoclonal antibodies against the" exact="calcitonin" post="gene-related peptide (CGRP) pathway for episodic (EM) and chronic"/>
 <result pre="and chronic migraine (CM) and compare them to those of" exact="topiramate" post="and onabotulinum toxin A as standard treatments for EM"/>
 <result pre="all randomised, placebo controlled, phase 3 trials of anti-CGRP monoclonals," exact="topiramate" post="and onabotulinum toxin A. A meta analysis of the"/>
 <result pre="trials of anti-CGRP monoclonal, whereas the pooled placebo frequency in" exact="topiramate" post="trials in EM was estimated to be 24.2% (95%"/>
 <result pre="hand, the pooled incidence of dropouts due to nocebo in" exact="topiramate" post="trials in EM was 9.2% (95% CI: 7 â€“"/>
 <result pre="monoclonal trials are average and comparable to those seen in" exact="topiramate" post="trials. Nocebo responses in trials of anti-CGRP monoclonals for"/>
 <result pre="other neurological disorders and were lower than those seen in" exact="topiramate" post="trials for EM. Nocebo responses in trials of anti-CGRP"/>
 <result pre="L( lmunozdelgado12@gmail.com) Background:Chronic cluster headache(CCH) pathophysiology involves an increase of" exact="calcitonin" post="gene-related peptide(CGRP) plasma levels during attacks,on analogy to what"/>
 <result pre="sample. A37 A case of supraorbital neuralgia successfully treated with" exact="pregabalin" post="Koutsokera, Pasqua Acquaviva Department, &quot;Thriassio&quot; General Hospital, Elefsis, Greece"/>
 <result pre="patient was advised to change his helmet and to receive" exact="pregabalin" post="to a total dose of 150mg. The patient improved"/>
 <result pre="with a long-standing diagnosis of sporadic HM treated successfully with" exact="valproic acid" post="who reports a mild difficulty in walking and a"/>
</results>
